Your browser doesn't support javascript.
loading
Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).
Kim, Myeong-Seon; Lee, A Jin; Shim, Seung-Hyuk; Jang, Eun Bi; Kim, Nam Kyeong; Kim, Min Kyung; Suh, Dong Hoon; Kim, Jeeyeon; Son, Joo-Hyuk; Kong, Tae-Wook; Chang, Suk-Joon; Hwang, Dong Won; Park, Soo Jin; Kim, Hee Seung; Yoo, Ji Geun; Lee, Sung Jong; Lee, Yoo-Young.
Affiliation
  • Kim MS; Department of Obstetrics and Gynecology, Chung-Ang University Gwangmyeong Hospital, College of Medicine Chung-Ang University, Seoul, Republic of Korea.
  • Lee AJ; Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Shim SH; Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Jang EB; Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.
  • Kim NK; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim MK; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Suh DH; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim J; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Son JH; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kong TW; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Chang SJ; Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Hwang DW; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Park SJ; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim HS; Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yoo JG; Department of Obstetrics and Gynecology, Daejeon St Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.
  • Lee SJ; Department of Obstetrics and Gynecology, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee YY; Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. yooyoung.lee@samsung.com.
Ann Surg Oncol ; 2024 Jul 03.
Article in En | MEDLINE | ID: mdl-38961041
ABSTRACT

BACKGROUND:

This report describes the oncologic outcomes for patients with advanced ovarian cancer who had bowel surgery performed by gynecologic oncologists (GOs) and compares the outcomes with those for bowel surgery performed by general surgeons (GSs) during maximal cytoreductive surgery.

METHODS:

Patients from six academic institutions who had FIGO stage III or IV ovarian cancer and underwent any bowel surgeries during maximal cytoreductive surgery were eligible for the study. The patients were divided into two groups according to whether bowel surgery was performed by a GO or a GS. In both groups, the GOs were mainly involved in extra bowel debulking procedures. Perioperative and survival outcomes were compared between the two groups.

RESULTS:

The 761 patients in this study included 113 patients who underwent bowel surgery by a GO and 648 who had bowel surgery by a GS. No discernible differences were observed in age, American Society of Anesthesiology (ASA) score, FIGO stage, histologic type, timing of cytoreductive surgery (primary or interval debulking surgery), or complications between the two groups. The GO group exhibited a shorter operation time than the GS group. Kaplan-Meier analysis showed no survival differences between the two groups. In the Cox analysis, non-serous cell types and gross residual diseases were associated with adverse effects on overall survival. However, performance of bowel surgery by a GO did not have an impact on survival.

CONCLUSION:

Performance of bowel surgery by a GO during maximal cytoreductive surgery is both feasible and safe. These results should be reflected in the training system for GOs regarding bowel surgery, and further research is needed to confirm that GOs can play a more leading role in performing extra-uterine procedures.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article
...